Ackman’s ‘wolf pack’ drove Allergan into foreign hands, former CEO says

Carly Helfand

CEO David Pyott and activist investor Bill Ackman called each other plenty of things during last year's months-long Valeant- takeover battle. But Pyott had a new one during a Senate committee hearing on Thursday.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS